Patent · US Active

Cyclic compound acting as PDE4 inhibitor

US10532986B2 · kind B2 · utility

1Cited by
0References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 2017
Grant dateJan 14, 2020
Priority date
Expiry dateAug 22, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are a phosphodiesterase-4 (PDE4) inhibitor and application thereof in preparation of a medication for treating a disease related to PDE4. Specifically disclosed is a compound as shown in formula (I) and a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.